US FDA panel says Gilead aztreonam safe, effective.    From Wordnik.com.  [WN.com - Articles related to Ford has balance sheet plan--executive chairman] Reference

Sciences Inc had shown its inhaled aztreonam to be safe.    From Wordnik.com.  [WN.com - Articles related to Ford has balance sheet plan--executive chairman] Reference

Cayston is contraindicated in patients with a known allergy to aztreonam.    From Wordnik.com.  [Gilead’s Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Yahoo! Finance] Reference

Gilead Sciences says panel recommends approval of cystic fibrosis treatment aztreonam.    From Wordnik.com.  [Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7] Reference

Gilead has two ongoing clinical studies evaluating aztreonam for inhalation solution.    From Wordnik.com.  [MarketWatch.com - Top Stories] Reference

Gilead submitted its NDA for aztreonam lysine for inhalation to the FDA on November 16.    From Wordnik.com.  [Nachrichten Ticker - www.finanzen.net] Reference

aztreonam lysine is a proprietary formulation of aztreonam developed specifically for inhalation.    From Wordnik.com.  [MarketWatch.com - Top Stories] Reference

We anticipate both European Commission and Canadian approval for aztreonam in the second half of 2009.    From Wordnik.com.  [Biotech Sector and Stocks Analysis from Seeking Alpha] Reference

Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational pro.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Foster City-based Gilead (NASDAQ: GILD) developed inhalable aztreonam lysine as a treatment of the bacteria.    From Wordnik.com.  [Jacksonville Business News - Local Jacksonville News | Jacksonville Business Journal] Reference

"We will continue to work closely with the FDA as it completes its review of aztreonam for inhalation solution.".    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

aztreonam formulated with lysine is a proprietary formulation of aztreonam developed specifically for inhalation.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

It is the latest bit of bad news for inhaled aztreonam lysine, a three-times-a-day antibiotic against the bacteria.    From Wordnik.com.  [Jacksonville Business News - Local Jacksonville News | Jacksonville Business Journal] Reference

Cayston (aztreonam for inhalation solution) 75 mg is an inhaled antibiotic for patients with cystic fibrosis who have.    From Wordnik.com.  [Gilead’s Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Yahoo! Finance] Reference

Inhalable aztreonam lysine has won conditional approval in Canada and, in September, Europe under the trade name Cayston.    From Wordnik.com.  [Los Angeles Business News - Local Los Angeles News | Los Angeles Business from bizjournals] Reference

The company said Cayston, or aztreonam lysine, is intended to be given three times per day for 28 days to treat the infection.    From Wordnik.com.  [R&D Mag - News] Reference

The organism was also determined to have heightened tolerance to aztreonam (MIC 16 mg l − 1) and cefepime (MIC 8 mg l − 1).    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

Gilead has also submitted applications for marketing approval of aztreonam lysine in Australia, Canada, Switzerland and Turkey.    From Wordnik.com.  [Health News from Medical News Today] Reference

This should create stoped as a sugar to, and not a remicade for, the expertise, skill, tax and coma of aztreonam practitioners.    From Wordnik.com.  [Wii-volution] Reference

Cayston contains aztreonam formulated with lysine, a proprietary formulation of aztreonam developed specifically for inhalation.    From Wordnik.com.  [Gilead’s Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Yahoo! Finance] Reference

Gilead expects the European Commission to issue its decision on the marketing authorization for aztreonam lysine later this year.    From Wordnik.com.  [Health News from Medical News Today] Reference

The committee voted 15 to 2 that Gilead has provided sufficient evidence of the safety and efficacy of aztreonam for inhalation solution.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Further, Gilead may not obtain marketing approval of aztreonam for inhalation solution in Australia, Switzerland and Turkey, where applications are also pending.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Despite the delay, we still see aztreonam lysine as a viable product, evidenced by management's commitment to initiate a phase II trial in non-CF bronchiectasis.    From Wordnik.com.  [Biotech Sector and Stocks Analysis from Seeking Alpha] Reference

aztreonam formulated with lysine is a proprietary formulation of aztreonam developed specifically for inhalation, which has orphan drug status in the US and Europe.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

Gilead is seeking FDA approval for inhalable aztreonam for the treatment of lung infection caused by Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

In Sep 2009, the drug received conditional marketing approval in Canada and Europe under the trade name Cayston (aztreonam lysine 75 mg powder and solvent for nebuliser solution).    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

® (aztreonam lysine 75 mg powder and solvent for nebuliser solution).    From Wordnik.com.  [THE MEDICAL NEWS] Reference

® (aztreonam for inhalation solution) versus tobramycin inhalation solution.    From Wordnik.com.  [Gilead’s Cayston® Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Yahoo! Finance] Reference

Compared with a rate of 93.3% in vancomycin/aztreonam-treated patients in the CE population.    From Wordnik.com.  [Forest Announces FDA Approval of Teflaro™ (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection - Yahoo! Finance] Reference

® (aztreonam for inhalation solution) for the improvement of respiratory symptoms in cystic fibrosis patients with.    From Wordnik.com.  [Gilead Sciences Announces Third Quarter 2010 Financial Results - Yahoo! Finance] Reference

"The FDA has not raised any significant concerns regarding the safety profile of aztreonam lysine.    From Wordnik.com.  [Nachrichten Ticker - www.finanzen.net] Reference

C) Monobactam (aztreonam)?.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference